ReviewBMJ oncology2024

Bedside implications of the use of surrogate endpoints in solid and haematological cancers: implications for our reliance on PFS, DFS, ORR, MRD and more.

Timothée Olivier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.